Can't find Insulin Lispro? Here are the best alternatives including Insulin Aspart, Insulin Glulisine, and Afrezza — how they compare and what to ask your doctor.
If you've been told your Insulin Lispro is out of stock — whether it's Humalog, Admelog, or the generic version — you need options, and you need them quickly. Going without rapid-acting insulin isn't safe, so knowing what alternatives exist and how to switch is essential.
The good news: there are several rapid-acting insulins that work very similarly to Insulin Lispro. Your doctor can help you transition to one of these alternatives safely, often without a significant change in how you manage your diabetes day to day.
In this article, we'll explain what Insulin Lispro is, how it works, and walk through the best alternatives available in 2026 — including how they compare on effectiveness, availability, and cost.
Insulin Lispro is a rapid-acting insulin analog used by people with Type 1 and Type 2 diabetes to control blood sugar spikes after meals. It's one of the most commonly prescribed mealtime insulins in the United States.
It's available under several brand names:
For a complete overview, see our article on what Insulin Lispro is and how to use it.
Insulin Lispro is a modified version of human insulin where two amino acids on the B chain are reversed (lysine and proline at positions 28 and 29). This small change prevents the insulin molecules from clumping together, which means it gets absorbed into your bloodstream much faster than regular human insulin.
Here's the timeline:
This rapid action makes it ideal for covering the blood sugar rise that happens after you eat. You inject it right before (or just after) a meal, and it works to bring your post-meal blood sugar back down. For more detail, read our deep dive on how Insulin Lispro works.
Insulin Aspart is probably the closest alternative to Insulin Lispro. It's another rapid-acting insulin analog made by Novo Nordisk, and it works in almost the same way.
Clinical studies have shown that Insulin Aspart and Insulin Lispro are essentially equivalent in their ability to control blood sugar. Many patients switch between the two without noticing any difference in effectiveness.
NovoLog is widely available at most pharmacies. The cash price for a 10 mL vial is approximately $150-$290, though discount programs and coupons can bring this down significantly. Fiasp is the ultra-rapid version, similar to how Lyumjev is the ultra-rapid version of Insulin Lispro.
Patients who need a straightforward, well-established alternative. If your insurance covers NovoLog on a preferred tier, this is often the easiest switch.
Insulin Glulisine is a rapid-acting insulin analog made by Sanofi. It has a slightly different molecular structure than Lispro or Aspart but achieves the same clinical goal.
Insulin Glulisine works very similarly to Insulin Lispro for most patients. It's slightly less commonly prescribed, which sometimes means it's more readily available during shortages of Lispro or Aspart.
Apidra is available at most pharmacies but may not always be on preferred formulary tiers. Cash prices for a 10 mL vial range from $200-$350. Check with your insurance to see if it's covered.
Patients who can't find either Insulin Lispro or Insulin Aspart. Because it's less commonly prescribed, pharmacy stock may be more consistent.
Afrezza is a completely different approach to rapid-acting insulin. Instead of injection, you inhale it through a small, pocket-sized inhaler. It's made by MannKind Corporation.
Afrezza has the fastest onset of any insulin on the market. Because it's inhaled, it's also completely needle-free, which some patients prefer.
Afrezza is available by prescription at most pharmacies. Cash prices are approximately $300-$500 per month depending on dosing needs. It requires a specific prescription — your doctor can't just substitute it for Insulin Lispro.
Patients who want a needle-free option or who have difficulty with injection-based insulin. Not ideal as a first-line substitute unless other options are also unavailable.
If you're specifically looking for another form of Insulin Lispro, Lyumjev is worth asking about. It's made by Eli Lilly and contains insulin lispro-aabc — the same core insulin molecule as Humalog, but with added excipients (treprostinil and citrate) that speed up absorption even further.
Lyumjev is technically a different product from standard Insulin Lispro, so it requires its own prescription. However, the transition is usually very smooth since the core insulin molecule is the same.
Lyumjev is available through Eli Lilly's distribution channels. It's covered by the Lilly Insulin Value Program at $35/month. Check with your insurance for formulary coverage.
Switching between rapid-acting insulins should always be done with your doctor's guidance. Here's what to expect:
For information on drug interactions to be aware of when starting any insulin, check our dedicated guide.
Not being able to fill your Insulin Lispro prescription is stressful, but you have options. Insulin Aspart (NovoLog) is the most similar alternative, followed by Insulin Glulisine (Apidra) and inhaled insulin (Afrezza). Your doctor can help you choose the best fit based on your health needs, insurance coverage, and what's currently in stock.
Before switching, try using Medfinder to see if any pharmacies near you still have Insulin Lispro available. You might be able to find it without needing to switch at all.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
